Participation of cAMP in the facilitatory action of β,γ-methylene ATP on the noradrenaline release from rabbit ear artery

Life Sciences

Volumn 65, Issue 25, 1999, Pages 2743-2753

  Ishii Nozawa, Reiko ^a   Shinozuka, Kazumasa ^b   Kunitomo, Masaru ^b   Hashimoto, Takao ^a   Takeuchi, Koichi ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

cAMP; Facilitatory action; Noradrenaline release; Preconjunctional purinoceptors; Rabbit ear artery; , Methylene ATP

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 8 BROMO CYCLIC AMP; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; CHOLERA TOXIN; CYCLIC AMP; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; N ETHYLMALEIMIDE; NORADRENALIN; PERTUSSIS TOXIN; PURINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; EAR ARTERY; FEMALE; MALE; NONHUMAN; NORADRENALIN RELEASE; RABBIT;

EID: 0033550326     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00543-3     Document Type: Article

References (54)

1. S. Z. Langer, Pharmacol. Rev. 32 337-362 (1981).
2. K. Starke, Annu. Rev. Pharmacol. Toxicol. 21 7-30 (1981).
3. M. F. Chesselet, 1984; Neuroscience. 12 347-375 (1984).
4. K. Starke, Rev. Physiol. Biochem. Pharmacol. 77 1-124 (1977).
5. K. Starke, Rev. Physiol. Biochem. Pharmacol. 107 73-146 (1987).
6. K. Starke, M. Gothert, and H. Kilbinger, Physiol. Rev. 69 864-989 (1989).
7. B. B. Fredholm and E. Lindgren, Acta, Physiol. Scand. 126 307-309 (1986).
8. B. B. Fredholm and E. Lindgreni, Acta Physiol. Scand. 130 95-105 (1987).
9. G. Heriting and C. Allgaieri, Cell. Mol. Neurobiol. 8 10-14 (1988).
10. C. Allgaier, E. Daschmann, J. Sievering and G. Heriting, J. Neurochem. 53 1629-1635(1989).
11. H. Majewski, M. Costa, S. Foucart, T. V. Murphy and I. F. Musgrave, Ann. N.Y. Acad. Sci. 604 266-275 (1990).
12. P. Hedqvjst and B. B. Fredholm, Naunyn-schmiedeberg's Arch. Pharmacol. 293 217-223 (1976).
13. B. B. Fredholm and P. Hedqvjst, 29 1635-1643 (1980).
14. T. W. Stone, Neuroscience. 6 523-555 (1981).
15. C. Su, Pharmacol. Rev. 23 397-411 (1983).
16. R. A. Olsson and J. D. Pearson, Physiol. Rev. 389 423-440 (1990).
17. J. A. Ribeiro, Adenosine and Adenine Nucleotides as Regulators of Cellular Function, J. W. Phillis (Eds.), 155-167, CRC Press, Boca Raton, Florida (1990).
18. D. P. Westfall, H. H. Dalziel and K. M. Forsyth, Adenosine and Adenine Nucleotides as Regulators of Cellular Function, J. W. Phillis (Eds.), 295-305, CRC Press, Boca Raton, Florida (1991).
19. R. Ishii, K. Shinozuka, Y. Kobayashi, K. Hattori, T. Hashimoto and K. Takeuchi, Naunyn Schmiedeberg's Arch. Pharmacol. 348 46-52 (1993a).
20. R. Ishii, K. Shinozuka, K. Hattori, R. A. Bjur, D. P. Westfall, K. Tskeuchi and T. Hashimoto, Proc. West. Pharmacol. Soc. 36 17-20 (1993b).
21. R. Ishii, K. Shinozuka, M. Kunitomo, T. Hashimoto and K. Takeuchi, J. Pharmacol. Exp. Ther. 273 1390-1395 (1995).
22. D. Van Calker, M. Muller and B. Hamprecht, J. Neurochem. 33 207-210 (1979).
23. D. M. F. Cooper and M. Rodbell, Nature. 282 517-518 (1979).
24. R. Ishii, K. Shinozuka, M. Kunitomo, K. Takeuchi and T. Hashimoto, Jpn. J. Pharmacol. 71 (Suppl. I), 80P (1996).
25. K. Shinozuka, R. Ishii, M. Kunitomo, M. Hashimoto, K. Takeuchi and T. Hashimoto, Jpn. J. Pharmacol. 71 (Suppl. I), 40P (1996).
26. R. Yamamoto and W. H. Cline, J. Pharmacol. Exp. Ther. 241 826-832 (1987).
27. L. C. Rump, V. Wolk, G. Ruff and P. Schollmeyer, J. Auton. Pharmacol. 12 97-108 (1992).
28. H. Johnston, H. Majewski and I. F. Musgrave, Br. J. Pharmacol. 91 773-781 (1987).
29. D. H. Versteeg and W. J. Florijin, Life Sci. 40 1237-1243 (1987).
30. I. F. Musgrave and H. Majewski, Naunyn-schmiedeberg's Arch. Pharmacol. 339 48-53(1989).
31. J. Abrahamsen and O. A. Nedergaard, Pharmacology & Toxicology 76 185-189 (1995).
32. H. Metzger, and E. Lindner, Artneimittelforsch./drug Res. 31 1248-1250 (1981).
33. S. J. Beebe, R. Holloway, S. R. Rannels and J. D. Corbin, J. Biol. Chem. 259 3539-3547 (1984).
34. K. B. Seamon and J. W. Daly, Adv. Cyclic Nucleotide Prot. Phosphor. Res. 20 1-150 (1996).
35. J. A. Beavo, Physiol. Rev. 75 725-748 (1995).
36. D. N. Harris, M. M. Asaas, M. B. Phillips, H. J. Goldedberg and M. J. Antonaccio, J. Cyclic Nucleotide Res. 5 125-134 (1979).
37. D. A. Brown and P. M. Dunn, Br. J. Pharmacol. 79 441-449 (1983).
38. M. Ui, Phosphoinositides and Receptor Mechanisms, J. M. Putney. (Eds.), 163-195, A. R. Liss. New York (1986).
39. G. Hertting and C. A. Allgaier, Cell. Mol. Neurobiol. 8 10-14 (1988).
40. R. A. Khan and A. G. Gilman, J. Biol. Chem. 259 6235-6240 (1984).
41. S. P. H. AlexAnder and A. P. D. Ford, Trend. Pharmacol. Sci. 17 385-388 (1996).
42. M. Griese, L. I. Gobran and S. A. Rooney, Am. J. Physiol. 261 L140-L147 (1991).
43. K. Sato, F. Okajima and Y. Kondo, Biochem. J. 283 281-287 (1992).
44. R. H. Henning, M. Duin, A. Den Hertog and A. Nelemans, Br. J. Pharmacol. 110 133-138(1993).
45. G. Burnstock, Adenosine and Adenine Nucleotides as Regulators of Cellular Function X, L. Bolis and R. W. Staub (Eds.), 107-118, Rauch Press, New York (1978).
46. T. W. Stone, Purines: Pharmacology and Physiological Roles, T. W. Stone (Eds), 245-251, Macmillan Press, London (1984).
47. K. Shinozuka, R. A. Bjur and D. P. Westfall, Naunyn-schmiedeberg's Arch. Pharmacol. 338 221-227 (1988).
48. K. Shinozuka, R. A. Bjur and D. P. Westfall, J. Pharmacol. Exp. Ther. 254 900-904(1990).
49. K. Forsyth, R. A. Bjur and D. P. Westfall, J. Pharmacol. Exp. Ther. 256 821-826(1991).
50. L. D. Todorov, R. A. Bjur and D. P. Westfall, J. Pharmacol. Exp. Ther. 268 985-989 (1994).
51. I. Matsuoka, Q. Zhou, H. Ishimoto and H. Nakanishi, Mol. Pharmacol. 47 855-862(1995).
52. B. F. King, J. Pintor, S. Wang, A. U. Ziganshin, L. E. Ziganshina and G. Burnstock, J. Pharmacol. Exp. Ther. 276 93-100 (1996).
53. H. H. Dalzel and D. P. Westfall, Pharmacol. Rev. 46 449-466 (1994).
54. Y. Saitoh and H. Nakata, Biochem. Biophys. Res. Comm. 219 469-474 (1996).